findmyKOL

Robert Hauser, MD

Enriched profile

Professor of Neurology, Molecular Pharmacology and Physiology; Director, USF Health Byrd Parkinson's Disease and Movement Disorders Center · University of South Florida

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Tampa, FL · Southeast · United StatesSpecialtyNeurologyFocusParkinson's Disease Mechanisms and Treatments+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding2002–2013

Robert Hauser is Professor of Neurology, Molecular Pharmacology and Physiology; Director, USF Health Byrd Parkinson's Disease and Movement Disorders Center at University of South Florida. OpenAlex indexes 553 publications with 31,320 citations (h-index 92); ClinicalTrials.gov lists 7 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Neurology profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 13 Oct 2026

Robert A. Hauser, MD, is Professor of Neurology, Molecular Pharmacology and Physiology at University of South Florida (USF Health Morsani College of Medicine), Department of Neurology. The public record shows 553 publications with 31,320 citations (h-index 92), centered on Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Botulinum Toxin and Related Neurological Disorders. It also documents an investigator role on 7 registered clinical trials, industry payments reported by 28 companies, 1 NIH-funded awards (2002–2013).

  • Most recent indexed publication: 2026 · Neurology and therapy
  • Top research focus: Parkinson's Disease Mechanisms and Treatments
  • 7 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 28 companies

Generated from the cited public record · current as of 13 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Parkinson's Disease7 trialsHypotension1 trialHypotension, Orthostatic1 trialIBS / Functional GI1 trialConstipation1 trial

Research focus

OpenAlex concept fingerprint
Parkinson's Disease Mechanisms and TreatmentsNeurological disorders and treatmentsBotulinum Toxin and Related Neurological DisordersParkinson's Disease and Spinal DisordersGenetic Neurodegenerative Diseases

Drugs & molecules

across trials, industry payments and publications
Gocovrigeneric · AmantadineClinical trials—Industry payments181Publications1Ingrezzageneric · ValbenazineClinical trials—Industry payments150Publications1Crexontgeneric · Carbidopa / levodopaClinical trials—Industry payments147Publications1Nourianzgeneric · IstradefyllineClinical trials—Industry payments41Publications1Inbrijageneric · LevodopaClinical trials—Industry payments5Publications4Sunosigeneric · SolriamfetolClinical trials—Industry payments1Publications1Botoxgeneric · Botulinum toxin type AClinical trials—Industry payments31Publications—Ongentysgeneric · OpicaponeClinical trials—Industry payments25Publications—Apokyngeneric · ApomorphineClinical trials—Industry payments1Publications—Myoblocgeneric · Botulinum toxin type BClinical trials—Industry payments1Publications—Radicavageneric · EdaravoneClinical trials—Industry payments1Publications—Radicava ORSClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
MDD US Operations, LLCClinical trials—Industry payments398Neurocrine BioSciences, Inc.Clinical trials—Industry payments182Amneal Pharmaceuticals LLCClinical trials—Industry payments116Abbvie Inc.Clinical trials—Industry payments106Kyowa Kirin, Inc.Clinical trials—Industry payments42Merz Pharmaceuticals, LLCClinical trials—Industry payments13Bayer Healthcare Pharmaceuticals Inc.Clinical trials—Industry payments12Adamas Pharmaceuticals, Inc.Clinical trials—Industry payments8H. Lundbeck A SClinical trials—Industry payments7Acorda Therapeutics, IncClinical trials—Industry payments6Jazz Pharmaceuticals Inc.Clinical trials—Industry payments4Sunovion Pharmaceuticals Inc.Clinical trials—Industry payments4Ucb SaClinical trials—Industry payments4Allergan, Inc.Clinical trials—Industry payments3Biogen, Inc.Clinical trials—Industry payments3Sage Therapeutics, Inc.Clinical trials—Industry payments3GE HealthCareClinical trials—Industry payments2Merck Sharp & Dohme CorporationClinical trials—Industry payments2Mitsubishi Tanabe Pharma America, Inc.Clinical trials—Industry payments2Tanabe Pharma America, Inc.Clinical trials—Industry payments2Zambon USA Ltd.Clinical trials—Industry payments2Annovis Bio Inc.Clinical trials1Industry payments—Chelsea TherapeuticsClinical trials1Industry payments—Enterin Inc.Clinical trials1Industry payments—Insightec,IncClinical trials—Industry payments1Medicure Pharma Inc.Clinical trials—Industry payments1Michael J. Fox Foundation for Parkinson's ResearchClinical trials1Industry payments—Neuron23 Inc.Clinical trials1Industry payments—pico-tesla Magnetic Therapies, LLCClinical trials1Industry payments—Revance Therapeutics, Inc.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
553publications

Distinct works indexed by OpenAlex, matched via ORCID; 22 in PubMed.

31,320citations

Total citations across indexed works.

92h-index

Hirsch index (OpenAlex). i10-index 297.

Clinical & industry

trials, payments and federal funding
7clinical trials

Investigator role on registered studies.

View trials ↓
28companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
1NIH grants · 2002–2013

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 13 Oct 2026

Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 13 Oct 2026

28 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Musculoskeletal

    99.8%
    Neuromuscular Blocker99.8%
    Onabotulinumtoxina81%Daxibotulinumtoxina-lanm19%Botox0%
    Part D + Part B<11 patients
    Acetylcholine Release Inhibitor0%
    Myobloc100%
    Part D<11 patients
  • Nervous system

    0.2%
    Benzodiazepine0.1%
    Clonazepam100%
    Part D<11 patients
    Gabapentinoids0.1%
    Gabapentin100%
    Part D<11 patients

    + 2 more classes in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 13 Oct 2026

1 NIH research award on record, funded 2002–2013 per NIH RePORTER. The latest:

All 219 award records: search, sort and filter.Explore →

Publications

Updated 13 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 13 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Stuart Isaacson68Stewart A. Factor59Rajesh Pahwa52Hubert H. Fernandez51Theresa A. Zesiewicz45William G. Ondo41Joohi Jimenez‐Shahed38Kelly L. Sullivan36Olivier Rascol33C. Warren Olanow32Joseph Jankovic30Daniel Truong30Caroline M. Tanner30Werner Poewe29Karen E. Anderson29Thomas B. Freeman25Mark Lew23Kelly E. Lyons21Alberto J. Espay21Theresa Zesiewicz21Peter A. LeWitt20Anthony E. Lang19Cynthia Comella19Tanya Simuni19Eric Molho18Fabrizio Stocchi18Mark Forrest Gordon18Mat D. Davis18David Stamler18Paolo Barone17Hadas Barkay17Grace Liang16Aaron Ellenbogen15Juha‐Matti Savola15Kapil D. Sethi14Kenneth Marek14David G. Standaert13John Seibyl13Lawrence Elmer13Khashayar Dashtipour12

Online presence

Updated 13 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/robert-hauser-md-0010f4a9

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • LinkedIn

    linkedin.com/in/robert-hauser-07135aa

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
  • Other

    health.usf.edu/medicine/neurology/faculty/hauser

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →health.usf.edu ↗
  • Google Scholar

    scholar.google.com/citations

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholar.google.com ↗
  • ResearchGate

    researchgate.net/profile/Robert-Hauser-2

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗

Mentions by others

where others cite or feature them
  • Facebook

    facebook.com/tampageneralhospital/posts/dr-robert-hauser-expert-neurologist-and-director-of-the-usf-health-parkinsons-di/1050181659810824

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗
  • Facebook

    facebook.com/usfhealth/videos/dr-robert-hauser-on-the-fda-approved-parkinsons-treatment-a-breakthrough-in-exte/866286364833046

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗
  • Other

    parkinson.org/library/podcast/108

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →parkinson.org ↗
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 13 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Board Certified

    American Board of Psychiatry and Neurology

    2012
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usf.edu ↗
  • provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usf.edu ↗
  • MBA

    University of South Florida

    2000
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →health.usf.edu ↗
  • MD

    Temple University School of Medicine

    1982
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →health.usf.edu ↗
  • Neurology residency

    Eastern Virginia Graduate School of Medicine, Norfolk General Hospital

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →reachmd.com ↗
  • Fellowship in Movement Disorders

    University of South Florida

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →reachmd.com ↗

Editorial & leadership roles

journal and society appointments
  • Chairman

    18th International Congress on Parkinson's Disease and Related Disorders (World Federation of Neurology), Miami

    2009
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →michaeljfox.org ↗
  • Fellow

    American Academy of Neurology (FAAN), 2004-present

    2004
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →health.usf.edu ↗
  • Member

    Movement Disorders Society

    1988
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →health.usf.edu ↗
  • Member

    American Academy of Neurology

    1988
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →health.usf.edu ↗
  • Past Chairman

    Interventional Neurology Section, American Academy of Neurology

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →michaeljfox.org ↗
  • Executive committee member

    Parkinson Study Group

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →michaeljfox.org ↗
  • Steering committee member

    NIH-sponsored Neuroprotective Exploratory Trials in Parkinson's Disease (NET-PD) program

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →michaeljfox.org ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.